• The Why And How Of Moving STD Testing Closer To the Point Of Care

    Sep 20 | Diagnostics World News Infectious disease diagnosis has been shifting from culture-based methods and immunoassays to molecular diagnostic testing, and more of the work is happening at the point of care (POC) rather than a centralized lab. More

  • Diagnosing An Outbreak: Advancing Diagnostic Technology For Infectious Diseases

    Sep 16 | Diagnostics World News | When a disease outbreak occurs, the first stage of the response is detection. During the initial stages of Zika and COVID-19 outbreaks, The World Health Organization (WHO) identified effective diagnostic testing as one of the key factors in monitoring and managing the spread of the disease. More

  • Lab Chip Aims To Amp Up Pathogen Detection At The Point Of Care

    Sep 15 | Diagnostics World News | Many of the biological assays currently done in clinical labs could be performed at the point of care (POC), thanks to microfluidic lab-on-chip devices for the rapid detection of pathogens, which might also be useful for pathogen identification, antibody susceptibility testing, or to measure host response based on cell count, proteins, or other biological entities. More

  • Street Medicine Program Bringing Point-Of-Care Testing To The Homeless

    Sep 13 | Diagnostics World News | A street medicine program is employing point-of-care testing (POCT) to mitigate the heightened risk of chronic diseases and death among the homeless in Los Angeles. Testing for glucose, hemoglobin, and hemoglobin A1c are currently available, but the menu will expand to include urine-based assays, she says. More

  • Metabolomics And Machine Learning Create ‘Signatures’ Of Viral Infections

    Sep 09 | Diagnostics World News | Over 18,000 different metabolites have been identified in humans that could potentially be altered by a respiratory virus infection, according to Benjamin Pinsky, M.D., Ph.D., medical director of the clinical virology laboratory at Stanford Health Care, speaking on advances in metabolomics at last week’s Next Generation Dx Summit. The changes can be detected by the coupling of liquid chromatography with mass spectrometry to produce host metabolic signatures. More

  • Testing Caveats Learned (And Relearned) During the Pandemic

    Sep 08 | Diagnostic World News | A long list of diagnostic adages have held true during the COVID-19 pandemic: a proactive and organized scientific approach yields excellent results, serology is not useful for detecting respiratory viruses, not all nucleic acid amplification tests perform equivalently, different specimens yield different results, pooling will miss low-level positives, RT-PCR is more sensitive than antigen tests, pretest probability is directly related to post-test-probability, and errors occur when implementations are rushed. More

  • The Lowdown On Rapid Antigen Testing For COVID-19

    Sep 07 | Diagnostics World News | The proper role of COVID-19 diagnostics, and especially rapid antigen tests, was the subject of a wide-ranging and mathematically oriented keynote presentation by Gerald Kost, M.D., Ph.D., director of the Point-of-Care Testing Center for Teaching and Research at the University of California, Davis, at the recent Next Generation Dx Summit. During his 30-minute talk, he took both the U.S. Food and Drug Administration (FDA) and the Cambodian government to task on their decision-making during the pandemic. More

  • Follow the Money: Alzheimer’s Disease Research, Wearables for Metabolic Health Disorders

    Sep 03 | Diagnostics World News | HealthTech SPAC funding, wearable fitness program for metabolic health disorders, multiple academic grants for dementia research and other causal connections in the brain, and more. More

  • Updated EUAs for COVID Variants, Kidney Disease Diagnostics Could Save Millions, New Products

    Sep 01 | Diagnostics World News | Budget analysis suggests substantial savings for early kidney disease diagnosis, Harvard-Israel diagnostic partnership, AI for detecting cancer in the GI tract, and update EUAs for Thermo Fisher and Spectrum Solutions. Plus new products from Smart Meter, Dosis, Rhinomed, and more. More

  • Quest Diagnostics Takes Lead On Making Healthcare More Consumer-Centric

    Aug 31 | Diagnostics World News | The M.O. of healthcare is to accommodate providers rather than individuals seeking care and that runs counter to the industry’s “triple aim” of improving the health of populations, enhancing the experience of care, and lowering per capita costs, according to Jay G. Wohlgemuth, M.D., chief medical officer for Quest Diagnostics Nichols Institute. The pandemic has spotlighted some of these well-known failings but also provided some lessons on how to operate in a more consumer-centric way. More
View more articles

 
DXX-Industry-spotlight

Acrobiosystems

Antigens & Antibodies for SARS-CoV-2 Diagnostic Kit Development

ACROBiosystems team has worked tirelessly since the genomic sequence of SARS-CoV-2 was first published, developing a serial of high-quality antigen and antibody reagents to support the development of the diagnostic kits. The products include the high quality S trimer, S RBD, S1, S2, N proteins mainly expressed by HEK 293 and paired antibodies with outstanding sensitivity tested on several platforms.

Click to learn more about ACRO’s hot matched antibody pairs and antigens.